Authors:
Xu, WC
Chen, WC
Luo, AP
Cui, H
Chen, YZ
Liu, SH
Citation: Wc. Xu et al., Suppression and compensation of the third-order dispersion effect on polarization modes in birefringent fibres, CHIN PHYS L, 18(9), 2001, pp. 1222-1224
Authors:
Xu, WC
Zhang, SM
Luo, AP
Chen, WC
Liao, CJ
Liu, SH
Wu, J
Lou, CY
Gao, YZ
Citation: Wc. Xu et al., Adiabatic enhanced compression of ultrashort pulses in fibres with slowly decreasing dispersion, CHIN PHYS L, 18(10), 2001, pp. 1360-1362
Citation: N. Liu et al., The nonlinear Schrodinger equation and the cross-phase modulation in erbium-doped fiber amplifiers, CHIN PHYS, 9(10), 2000, pp. 753-756
Authors:
Rosenheck, R
Cramer, J
Jurgis, G
Perlick, D
Xu, WC
Thomas, J
Henderson, W
Charney, D
Citation: R. Rosenheck et al., Clinical and psychopharmacologic factors influencing family burden in refractory schizophrenia, J CLIN PSY, 61(9), 2000, pp. 671-676
Authors:
Rosenheck, R
Chang, S
Choe, Y
Cramer, J
Xu, WC
Thomas, J
Henderson, W
Charney, D
Citation: R. Rosenheck et al., Medication continuation and compliance: A comparison of patients treated with clozapine and haloperidol, J CLIN PSY, 61(5), 2000, pp. 382-386
Citation: Wc. Xu et al., Novel protein kinase C inhibitors: Synthesis and PKC inhibition of beta-substituted polythiophene derivatives, BIOORG MED, 9(15), 1999, pp. 2279-2282
Authors:
Rosenheck, R
Evans, D
Herz, L
Cramer, J
Xu, WC
Thomas, J
Henderson, W
Charney, D
Citation: R. Rosenheck et al., How long to wait for a response to clozapine: A comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia, SCHIZO BULL, 25(4), 1999, pp. 709-719
Authors:
Rosenheck, R
Cramer, J
Allan, E
Erdos, J
Frisman, LK
Xu, WC
Thomas, J
Henderson, W
Charney, D
Citation: R. Rosenheck et al., Cost-effectiveness of clozapine in patients with high and low levels of hospital use, ARCH G PSYC, 56(6), 1999, pp. 565-572
Authors:
Rosenheck, R
Dunn, L
Peszke, M
Cramer, J
Xu, WC
Thomas, J
Charney, D
Citation: R. Rosenheck et al., Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia, AM J PSYCHI, 156(1), 1999, pp. 88-93
Authors:
Rosenheck, R
Cramer, J
Xu, WC
Grabowski, J
Douyon, R
Thomas, J
Henderson, W
Charney, D
Citation: R. Rosenheck et al., Multiple outcome assessment in a study of the cost-effectiveness of clozapine in the treatment of refractory schizophrenia, HEAL SERV R, 33(5), 1998, pp. 1237-1261